Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this manuscript type, please feel free to reach out to Mohamed directly at [email protected], or contact ASCPT Journal Family Managing Editor Alethea Gerding at [email protected].
Episodes
PSP Call for Papers: Pregnancy
Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique opportunity to exchange knowledge and scientific perspectives across the global quantitative clinical pharmacology community. Our guests for this episode expand on the relevance and importance of this theme, what types of research they’re hoping to receive, and why a global approach to highlighting this research is crucial.
Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”
Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT website, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in Clinical Pharmacology & Therapeutics, here.
Call for Papers: Artificial Intelligence and Machine Learning
Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled “The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.” Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. Qi Liu to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!
Call for Papers: Real-World Evidence and Real-World Data
Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial team will be considering submissions for the issue through early September of 2023. This Call was developed around the ASCPT 2023 Annual Meeting Pre-Conference “Advancing the Utilization of Real-World Data (RWD) and Real-World Evidence (RWE) in Clinical Pharmacology and Translational Research,” so if you have questions about the suitability of the topic for inclusion in the issue, please feel free to contact Paulien or pre-conference co-Chairs Dr. Karen Rowland Yeo and Dr. Jing Liu.